Opera Ltd ADROPRA
Price$17.63Intrinsic value$24.1637% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $614.8M+27.9% YoYTTM through 31 Dec 2025
Net Income $108.3M+34.1% YoYTTM through 31 Dec 2025
Free Cash Flow $112.2MTTM through 31 Dec 2025

Margins

Current
Gross Margin63.1%
EBITDA Margin17.7%
Operating Margin17.0%
Net Margin17.6%

Returns

11.6%ROE
9.5%ROA
12.5%ROIC

Balance Sheet Health

Debt / Equity0.01x
Current Ratio1.88x
Net Debt-$133Mnet cash position
Cash & Equivalents$155.5M

Quality Metrics

Piotroski F-Score6 / 9
FCF Margin18.2%
Rule of 4038.1
Earnings-Beat Rate25.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $614.8M
Diluted EPS
'19'20'21'22'23'24'25
FY2025: $1.19

Dividend

$0.80Per share, FY20265.63%Yield

Capital Allocation

Capex Intensity0.9%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.